An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer

BACKGROUND: Debates exist on the treatment decision of the stage II/III colorectal cancer (CRC) due to the insufficiency of the current TNM stage‐based risk stratification system. Epithelial–mesenchymal transition (EMT) and tumor microenvironment (TME) have both been linked to CRC progression in rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Du, Wang, Wei, Zhong, Min‐Er, Fan, Dejun, Liu, Xuanhui, Li, Cheng‐Hang, Huang, Ze‐Ping, Zhu, Qiqi, Lv, Min‐Yi, Hu, Chuling, Duan, Xin, Wu, Xiao‐Jian, Gao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134284/
https://www.ncbi.nlm.nih.gov/pubmed/36629124
http://dx.doi.org/10.1002/cam4.5534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134284/
https://www.ncbi.nlm.nih.gov/pubmed/36629124
http://dx.doi.org/10.1002/cam4.5534

Ejemplares similares